SUMMARY One hundred and forty eight patients (69 women and 79 men) with often recurring genital herpes were observed for two months. Men had 119 observed recurrences and women 104. The attacks were significantly longer in men than women (8.7 days v 6.6 days, p = 0.005). Significantly more women complained of symptoms, however, and when symptoms occurred they were more severe. Other significant differences between men and women included age (men were older than women); more men had previously had sexually transmitted diseases; more men had infected a sexual partner, but fewer knew the source of their infection; and men had more lesions at each attack. Positive viral culture results were shown to depend on the amount oferythema, the number oflesions, and the presence of vesicles.
Numbers of patients with genital herpes attending sexually transmitted disease (STD) clinics in the United Kingdom (UK) and the United States of America (USA) have increased dramatically in recent years.'`Most of these patients have severe first episode genital herpes, but the proportion attending again with recurrent infection has increased significantly. 4 Although primary attacks last longer and are more severe than recurrences,5 it is the recurrent nature of the condition that is responsible for the anxiety and psychosexual dysfunction often seen in these patients. 67 Despite many reports on genital herpes, only a handful of studies have looked at the clinical features, viral isolation, and likelihood of transmission in patients with recurrent infection,5 512 and only small numbers ofpatients were studied in all but one ofthese studies. 5 We undertook the study published here to review the natural history of recurrent herpes, to gather information concerning the source and transmission of the infection, to assess the patients' understanding of the condition, and to compare these features in men and women.
Patients and methods
Patients with recurrent genital herpes who had participated in a trial of suppressive acyclovir treatment were entered into the study. All were aged 19 or over and gave a history of at least six attacks of herpes a year. We used a standardised schedule to record the frequency and severity of previous recurrences and treatments, the source of the infection and whether other sexual partners had been infected, and each patient's knowledge about herpes. We observed patients for two months while they received no treatment. During each recurrence patients were asked to return to the clinic, where a history was taken, clinical features noted, and specimens sent to the laboratory for viral culture. Symptoms were graded on a scale of 0 to 3 (0 = none, 1 = mild, 2 = moderate, 3 = severe). Statistical tests used included the x2 and Mann Whitney U-tests. For ethical reasons homosexual men were not tested for antibodies to human immunodeficiency virus (HIV).
Results

PATIENT DEMOGRAPHY AND HISTORY OF PREVIOUS ATTACKS
The study population comprised 69 women and 79 men; 14 of the men were homosexual and the remaining heterosexual. Table 1 shows that the men were significantly older than the women (mean ages 31-8 v 103 During the two month observation period, the mean number of attacks was 151 in both sexes (range 1-4). The total number of attacks observed was 1 19 in men and 104 in women. These attacks were confirmed virologically from at least one site in 75 of the attacks in men and in 64 of the attacks in women. The mean time between attacks was 24-7 days in men and 28.5 days in women (not significant). The mean (SD) duration of attacks was 8-7 (5.7) days in men and 6-6 (3.2) days in women (p = 0 005). Table 3 shows that more women than men complained of local symptoms (pain, itching, or dysuria). For example, pain occurred in 54 attacks in women compared with only 43 in men (p = 0.02). The systemic symptoms of headache and malaise were also more common in women; malaise was associated with 52 out of 104 of attacks in women compared with only 
Symptoms
Discussion
This study showed that significantly more women with recurrent herpes suffer from pain, itching, dysuria, headache, and malaise than their male counterparts, and that these symptoms tended to be more severe. As a third of women reported that their attacks were associated with menstruation, some of the symptoms in women could be related to premenstrual and menstrual factors. It is of interest, however, that men had significantly longer attacks than women. HIV infection could be a possible reason for the longer duration of symptoms in men, though this was unlikely to be important in this study as only 14 of the men were homosexual and only a quarter of homosexual men attending this clinic are known to be HIV positive.'3 The differences in symptomatology between men and women are similar to those reported by Corey and colleagues from Seattle. 5 In this study more women than men knew the source of their infection, but fewer had infected a contact or informed their current sexual partner of their condition. These findings suggest that the women were more careful in the way that they conducted their sexual relationships, but were less open about their condition, perhaps reflecting a fear that disclosure would receive an unsympathetic response from the partner. A surprising feature ofthis study was the large number of patients who claimed that they had not received advice about abstaining from sexual intercourse during attacks or about the need for cervical cytology. The need to reinforce information to all patients is apparent, particularly to men about transmission and to women about cytology and about risks to neonates.
Men had significantly more lesions at each attack than women. These findings are similar to those of Corey et al,5 though they reported more lesions per episode (7.5 for men, 4-8 for women) than we found. Our findings in this respect agree more closely with those of Guinan et al, who found that 78% of women had only a single lesion at each recurrence.' Positive viral culture results were shown to depend on the amount oferythema, the number oflesions, and the presence of vesicles. Other studies have confirmed that the optimum time for taking samples for herpes culture is at the early stages of recurrence, when erythema is at its maximum and vesicles are still present.5`' Even at the crusting stage, however, 36% of lesions in our study were culture positive. This suggests that even when crusts are present a viral culture may still be worthwhile and, as such lesions are potentially infectious, patients should be advised to refrain from sexual intercourse until healing is complete. The infection can also be transmitted when 106 patients are asymptomatic,'4 but this issue was not addressed in our study.
In summary, we have identified the following differences between men and women; women get worse symptoms, but men have longer duration of attacks and more lesions at-each attack. Men were more conscious of attacks being provoked by sexual activity, and had previously had a sexually transmitted disease. More women knew the source of their infection, but fewer told or infected a new sexual partner. These factors may be important when diagnosing, treating, and counselling patients with herpes.
